NIH-funded research Career grant

Understanding how soft tissue sarcomas respond to radiation therapy

Official title: Non-invasive characterization of human soft tissue sarcoma response to radiation therapy

Funded at Stanford University · NIH-10902079 · Data updated 2026-11-12

This study is looking at tumor and blood samples from patients with soft tissue sarcomas to find out why some tumors don’t respond well to radiation therapy, with the goal of making radiation treatment more effective for those patients.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 15, 2022
Project endJune 30, 2026
Funding year2024
Award (this year)$262,249
NIH project number5K08CA255425-03
Project IDNIH-10902079 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with soft tissue sarcomas who are undergoing radiation therapy.

Less likely to help

Patients with other types of cancers or those not receiving radiation therapy may not benefit from this research.

What this research studies

This research focuses on analyzing human tumor and blood samples from patients with soft tissue sarcomas to identify factors that contribute to radiation resistance. By understanding these mediators, the research aims to enhance the effectiveness of radiation therapy for these patients. The project is led by Dr. Everett Moding at Stanford University, who is working under the mentorship of experts in genomics, tumor immunology, and radiation biology. The approach combines clinical insights with advanced laboratory techniques to develop better treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved radiation therapy outcomes for patients with soft tissue sarcomas.

How similar studies have gone: Previous research has shown promise in using tumor and blood sample analysis to improve cancer treatment outcomes, indicating that this approach has potential for success.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Moding, Everett James — Stanford University
  • Study coordinator: Moding, Everett James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.